Effectiveness of a Community-based Health Education Intervention on Prostate Cancer Fatalism: a Quasi-experimental Study

Overview

Journal Pan Afr Med J

Date 2024 Nov 15

PMID 39545027

Authors

Ruth Gathoni Mbugua

Simon Karanja

Sherry Oluchina

Affiliations

Soon will be listed here.

Abstract

Introduction: prostate cancer is categorized as the most common cancer in males in 2020 in Kenya at 21.9%. The major challenge with prostate cancer in Low and Middle-Income Countries is the presentation of patients with advanced disease. The rate of prostate cancer screening is low across African countries which has been associated with low knowledge and fatalistic beliefs. The study aimed to assess the effectiveness of community-based health education on prostate cancer fatalism.

Methods: the study design was quasi-experimental. The study was conducted in Kiambu County in the Gatundu North and Kiambu sub-counties in Kenya. A total of 288 men were selected per arm of the study using stratified random sampling. Data were collected using a structured questionnaire at baseline and post-intervention. The intervention was health education through home visits by a Community Health Worker.

Results: in the study, fatalism was associated with prostate cancer screening (P<0.05). There was a significant decrease in prostate cancer fatalism for the attributes of pessimism, pre-determination, and death inevitability in the intervention arm post-intervention. In contrast, in the control arm, there was no significant decrease. Post-intervention, the proportion of respondents with a high perception of fatalism decreased from 51% to 23.6% (P<0.05) in the intervention arm. In contrast, in the control arm, there was no significant decrease.

Conclusion: prostate cancer fatalism significantly influenced prostate cancer screening. Community-based health education significantly reduced pessimism, death inevitability, and pre-destination beliefs about prostate cancer. Tailored culturally relevant health education is an effective strategy to address fatalistic beliefs.

References

Espinosa de Los Monteros K, Gallo L . The relevance of fatalism in the study of Latinas' cancer screening behavior: a systematic review of the literature. Int J Behav Med. 2010; 18(4):310-8. PMC: 3212691. DOI: 10.1007/s12529-010-9119-4. View

Vrinten C, Wardle J, Marlow L . Cancer fear and fatalism among ethnic minority women in the United Kingdom. Br J Cancer. 2016; 114(5):597-604. PMC: 4782206. DOI: 10.1038/bjc.2016.15. View

Mitchell J, Manning M, Shires D, Chapman R, Burnett J . Fatalistic Beliefs About Cancer Prevention Among Older African American Men. Res Aging. 2015; 37(6):606-22. PMC: 4334730. DOI: 10.1177/0164027514546697. View

Kobayashi L, Smith S . Cancer Fatalism, Literacy, and Cancer Information Seeking in the American Public. Health Educ Behav. 2015; 43(4):461-70. PMC: 5123630. DOI: 10.1177/1090198115604616. View

Ojewola R, Oridota E, Balogun O, Ogundare E, Alabi T, Banjo O . Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria. Pan Afr Med J. 2017; 27:151. PMC: 5567951. DOI: 10.11604/pamj.2017.27.151.10605. View

Bugoye F, Leyna G, Moen K, Mmbaga E . Knowledge, Perceived Risk and Utilization of Prostate Cancer Screening Services among Men in Dar Es Salaam, Tanzania. Prostate Cancer. 2019; 2019:2463048. PMC: 6913246. DOI: 10.1155/2019/2463048. View

Powe B, Finnie R . Cancer fatalism: the state of the science. Cancer Nurs. 2004; 26(6):454-65. DOI: 10.1097/00002820-200312000-00005. View

Mutua K, Pertet A, Otieno C . Cultural factors associated with the intent to be screened for prostate cancer among adult men in a rural Kenyan community. BMC Public Health. 2017; 17(1):894. PMC: 5701294. DOI: 10.1186/s12889-017-4897-0. View

Niederdeppe J, Gurmankin Levy A . Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2007; 16(5):998-1003. DOI: 10.1158/1055-9965.EPI-06-0608. View

10.

Powe B, Hamilton J, Brooks P . Perceptions of cancer fatalism and cancer knowledge: a comparison of older and younger African American women. J Psychosoc Oncol. 2006; 24(4):1-13. DOI: 10.1300/J077v24n04_01. View

11.

Marlow L, Ferrer R, Chorley A, Haddrell J, Waller J . Variation in health beliefs across different types of cervical screening non-participants. Prev Med. 2018; 111:204-209. PMC: 5945192. DOI: 10.1016/j.ypmed.2018.03.014. View

12.

Cobran E, Wutoh A, Lee E, Odedina F, Ragin C, Aiken W . Perceptions of prostate cancer fatalism and screening behavior between United States-born and Caribbean-born Black males. J Immigr Minor Health. 2013; 16(3):394-400. PMC: 3825837. DOI: 10.1007/s10903-013-9825-5. View

13.

Moreno P, Yanez B, Schuetz S, Wortman K, Gallo L, Benedict C . Cancer fatalism and adherence to national cancer screening guidelines: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Cancer Epidemiol. 2019; 60:39-45. PMC: 10424711. DOI: 10.1016/j.canep.2019.03.003. View

14.

Lange L, Piette J . Personal models for diabetes in context and patients' health status. J Behav Med. 2006; 29(3):239-53. DOI: 10.1007/s10865-006-9049-4. View

15.

Odedina F, Akinremi T, Chinegwundoh F, Roberts R, Yu D, Reams R . Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009; 4 Suppl 1:S2. PMC: 2638461. DOI: 10.1186/1750-9378-4-S1-S2. View

16.

Cobran E, Hall J, Aiken W . African-American and Caribbean-Born Men's Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study. J Cancer Educ. 2017; 33(3):640-648. PMC: 5511759. DOI: 10.1007/s13187-017-1167-x. View

17.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

18.

Adeloye D, David R, Aderemi A, Iseolorunkanmi A, Oyedokun A, Iweala E . An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(4):e0153496. PMC: 4830589. DOI: 10.1371/journal.pone.0153496. View

19.

Kangmennaang J, Mkandawire P, Luginaah I . What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia?. J Cancer Epidemiol. 2016; 2016:7962502. PMC: 4736914. DOI: 10.1155/2016/7962502. View

20.

Powe B, Cooper D, Harmond L, Ross L, Mercado F, Faulkenberry R . Comparing knowledge of colorectal and prostate cancer among African American and Hispanic men. Cancer Nurs. 2009; 32(5):412-7. DOI: 10.1097/NCC.0b013e3181aaf10e. View